default author photo

Bao-dong qin

Government of the People's Republic of China - Shanghai Changzheng Hospital

Shanghai

China

SCHOLARLY PAPERS

3

DOWNLOADS

196

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Prognostic Value of Diverse TP53 Mutations in Metastatic Cancers: An Analysis of the Cbioportal Database

Number of pages: 31 Posted: 24 Aug 2021
Ke Liu, Yan Ling, Hui-Min Wang, Xiao-Dong Jiao, Bao-dong qin, Ying Wu, Xi He, Xiao-Peng Duan, Bing Li, Xiao Zou and Yuan-Sheng Zang
Naval Medical University (SMMU), Naval Medical University (SMMU), Naval Medical University (SMMU), Government of the People's Republic of China - Shanghai Changzheng Hospital, Government of the People's Republic of China - Shanghai Changzheng Hospital, Naval Medical University (SMMU), Naval Medical University (SMMU), Government of the People's Republic of China - Shanghai Changzheng Hospital, Burning Rock Biotech, Burning Rock Biotech and Government of the People's Republic of China - Department of Medical Oncology
Downloads 79 (809,932)

Abstract:

Loading...

2.

Effect of Smoking Status on the Efficacy of EGFR-TKI Plus Anti-Angiogenic Agent in Advanced EGFR-Mutant NSCLC

Number of pages: 22 Posted: 07 Feb 2022
Bao-dong qin, Xiao-Dong Jiao, Ying Wu, Yan Wang, Yan Ling, Ke Liu and Yuan-Sheng Zang
Government of the People's Republic of China - Shanghai Changzheng Hospital, Government of the People's Republic of China - Shanghai Changzheng Hospital, Government of the People's Republic of China - Department of Medical Oncology, Government of the People's Republic of China - Department of Medical Oncology, Government of the People's Republic of China - Department of Medical Oncology, Government of the People's Republic of China - Department of Medical Oncology and Government of the People's Republic of China - Department of Medical Oncology
Downloads 68 (891,180)

Abstract:

Loading...

EGFR-mutant NSCLC, EGFR-TKI, Anti-angiogenic agent, Smoking status

3.

Low-Dose Anti-VEGFR2 Therapy Promotes Anti-Tumor Immunity in Lung Adenocarcinoma by Down-Regulating the Expression of Layilin on Tumor-Infiltrating CD8 +T Cells

Number of pages: 35 Posted: 14 Mar 2022
Biaolong Yang, Biaolong Deng, Xiao-Dong Jiao, Bao-dong qin, Yi Lu, Weiqi Zhang, Yixian Guo, Shiqi Chen, Dan Li, Bin Li and Yuan-Sheng Zang
Government of the People's Republic of China - Shanghai Changzheng Hospital, Shanghai Jiao Tong University (SJTU) - Department of Microbiology and Immunology, Government of the People's Republic of China - Shanghai Changzheng Hospital, Government of the People's Republic of China - Shanghai Changzheng Hospital, Shanghai Jiao Tong University (SJTU) - Department of Ophthalmology, Shanghai Jiao Tong University (SJTU) - Department of Microbiology and Immunology, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Immunology, Naval Medical University (SMMU), Shanghai Jiao Tong University (SJTU) - Department of Microbiology and Immunology, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Immunology and Government of the People's Republic of China - Department of Medical Oncology
Downloads 49 (1,074,648)

Abstract:

Loading...

Lung adenocarcinoma (LUAD), LAYN (Layilin), immunotherapy, Tumor-infiltrating exhausted CD8+T, anti-angiogenesis therapy